Epsilon M&A Deal Report - William Ransom & Son
Transaction Multiples for the Valuation of Private Companies
WCM (2011) / William Ransom & Son
No EMAT :
28598
Announced Date :
04/07/2011
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
WCM (2011)
Target :
William Ransom & Son
Country :
England
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Founded in 1846, William Ransom & Son engages in: 1. C ontract manufacturing of licensed pharmaceutical liquids and creams for third parties; and botanical extracts for sale to third parties,...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
| Date | Acquirer | Target | Country | Multiples | See details |
| 01/09/2010 | McBride | Dermacol as (now McBride Czech) | Czech Republic | * | 28492 |
| 29/06/2009 | Vetoquinol SA | Animal Health Division of Wockhardt | India | * | 27520 |
Source: Epsilon Research / EMAT
